A mouse pancreatic organoid model to compare PD-L1 blocking antibodies
Immune checkpoint inhibitors (ICIs) have changed the therapeutic landscape for cancer patients, but diabetes, a rare, severe immune-related endocrinopathy, is linked to ICI therapy. It is unclear whether glycosylation of ICIs may play a role in the development of this adverse event and how the physi...
Saved in:
Main Authors: | Guangyuan Li (Author), Susmita Ghosh (Author), JuMe Park (Author), Hyunsu Shin (Author), Mamatha Garige (Author), Gregory Reaman (Author), Carole Sourbier (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigenetic small-molecule screen for inhibition and reversal of acinar ductal metaplasia in mouse pancreatic organoids
by: Kalina R. Atanasova, et al.
Published: (2024) -
Patient‐derived pancreatic tumour organoid implantation establishes novel pre‐cachexia mouse models
by: Merel R. Aberle, et al.
Published: (2023) -
Application and challenge of pancreatic organoids in therapeutic research
by: Jin Chen, et al.
Published: (2024) -
Pancreatic Progenitors and Organoids as a Prerequisite to Model Pancreatic Diseases and Cancer
by: Meike Hohwieler, et al.
Published: (2019) -
CFTR Expression Analysis for Subtyping of Human Pancreatic Cancer Organoids
by: Alexander Hennig, et al.
Published: (2019)